Impact of switching to tenofovir alafenamide on weight gain as compared to maintaining a non-tenofovir alafenamide containing regimen

Evaluate the impact of switching to an anti-retroviral regimen containing tenofovir alafenamide (TAF) on weight and the development of metabolic complications compared to remaining on a non-TAF containing regimen. Single-center retrospective case-control study. We evaluated people living with human...

Descripción completa

Detalles Bibliográficos
Autores principales: Darnell, Julia, Jain, Sonia, Sun, Xiaoying, Qin, Huifang, Reynolds, Timothy, Karris, Maile Young, Hill, Lucas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389919/
https://www.ncbi.nlm.nih.gov/pubmed/34449491
http://dx.doi.org/10.1097/MD.0000000000027047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389919/
https://www.ncbi.nlm.nih.gov/pubmed/34449491
http://dx.doi.org/10.1097/MD.0000000000027047

Ejemplares similares